地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话:18372041646
传真:18771997407
邮箱:sales@amyjet.com

Zedira是一家临床阶段的生物技术公司,专门从事转谷氨酰胺酶的研究,开发一系列小分子药物候选物。Zedira公司正致力于药物发现的前沿领域,该领域涉及阻止调节失调的转谷氨酰胺酶的小分子。此外,Zedira是一个全球品牌,专门用于转谷氨酰胺酶领域的研发和诊断试剂,其独特和高质量的产品有助于推动转谷氨酰胺酶的研究和应用。
Zedira is a clinical stage biotech company specialised in transglutaminase. Zedira conducts its own development of small molecular drug candidates. In doing so, the company is working at the cutting edge of drug discovery involving small molecules that block dysregulated transglutaminases. In addition, Zedira is a global brand for specialty reagents for research & development as well as diagnostics in the transglutaminase field. Numerous unique and high quality products help pushing forward transglutaminase-related science – both in academia and industry.
Zedira公司主要产品:
Transglutaminases
Microbial Transglutaminase
Assays and Substrates
Inhibitors
Antibodies and Microarrays
Proteases
Protein Labeling
Blood Coagulation
Cereal Proteins
Celiac Disease Products
更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
Zedira产品详情请咨询我司客服人员:
| 产品编号 | 产品名称 | 产品规格 |
| A003 | Polyclonal antibody to human tissue transglutaminase (TG2) | 100 ug |
| A004 | Monoclonal antibody to tissue transglutaminase (TG2) | 100 ug |
| A008 | Polyclonal antibody to human transglutaminase 5 (TG5) | 500 ug |
| A011 | Monoclonal antibody to gliadin (clone XGY1) | 1 mg |
| A013 | Monoclonal antibody to gliadin (clone XGY7) | 1 mg |
| A014 | Polyclonal antibody to human tissue transglutaminase (TG2) | 500 ug |
| A015 | Polyclonal antibody to human epidermal transglutaminase (TG3) | 500 ug |
| A016 | Polyclonal antibody to human blood coagulation factor XIII (A-subunit) | 500 ug |
| A017 | Polyclonal antibody to human neuronal transglutaminase (TG6) | 500 ug |
| A018 | Polyclonal antibody to human keratinocyte transglutaminase (TGI) | 500 ug |
| A020 | Polyclonal antibody to microbial protransglutaminase (pro-MTG, pro-BTG) | 500 ug |
| A021 | Polyclonal antibody to human plasminogen (rhPLG) | 500 ug |
| A022 | Polyclonal antibody to human prostate transglutaminase (TG4) | 500 ug |
| A023 | Monoclonal antibody to N'-ly-L-glutamylpL-lysine-isopeptide bond | 100 ug |
| A024 | Monoclonal Antibody to microbial (bacterial) Transglutaminase | 100 ug |
| A028 | FITC-labeled polyclonal antibody to human TG2 | 200 ug |
| A029 | FITC-labeled polyclonal antibody to human TGI | 200 ug |
| A030 | FITC-labeled polyclonal antibody to human TG3 | 200 ug |
| A031 | FITC-labeled polyclonal antibody to human TG6 | 200 ug |
| A032 | FITC-labeled polyclonal antibody to human factor XIII (A-subunit) | 200 ug |
| A033 | Monoclonal antibody to human TG2 (Catalytic Domain, clone XTG17) | 200 ug |
| A034 | Monoclonal antibody to human TG2 (Beta Sheet Domain, clone XTG 1 1) | 200 ug |
| A035 | Monoclonal antibodies to gliadin (Set No 1) | 1 Set |
| A036 | Monoclonal antibody to human TG2 (Beta Barrel 1 Domain, clone XTG21) | 200 ug |
| A037 | Monoclonal antibody to human TG2 (Beta Barrel 2 Domain, clone XTG1 8) | 200 ug |
| A040 | Polyclonal antibody to human transglutaminase 7 (TG7) | 200 ug |
| A042 | Monoclonal antibody to human TGI (clone XTG3 1) | 200 ug |
| A044 | FITC-labeled polyclonal antibody to human TG5 | 200 ug |
| A046 | D-Dimer monoclonal mouse antibody, clone 3B6 | 100 ug |
| A047 | D-Dimer monoclonal mouse antibody, clone 1 D2 | 100 ug |
| A051 | Biotinylated polyclonal antibody to microbial transglutaminase (MTG) | 50 ug |
| A052 | Biotinylated polyclonal antibody to human factor XIII (A-subunit) | 50 ug |
| A053 | Biotinylated polyclonal antibody to human TG2 | 50 ug |
| A054 | Monoclonal antibody to gliadin (clone XGY6) | 1 mg |
| A057 | Monoclonal antibody to deamidated gliadin | 100 ug |
| A058 | Monoclonal antibody to gliadin (clone XGY5) | 1 mg |
| A059 | Monoclonal antibody to gliadin (clone XGY9) | 1 mg |
| A060 | Monoclonal antibody to gliadin (clone XGY10) | 1 mg |
| A061 | Monoclonal antibody to gliadin (clone XGY 1 6) | 1 mg |
| A062 | Monoclonal antibody to deamidated and non-deamidated gliadin | 100 ug |
| A063 | Monoclonal antibody to gliadin (clone XGY2) | 1 mg |
| A064 | Monoclonal antibody to gliadin (clone XGY4) | 1 mg |
| A065 | Monoclonal antibody to gliadin (clone XGY8) | 1 mg |
| A066 | Monoclonal antibody to gliadin (clone XGY 1 2) | 1 mg |
| A067 | Monoclonal antibody to gliadin (clone XGY 1 5) | 1 mg |
| A068 | Monoclonal antibody to gliadin (clone XGY 1 7) | 1 mg |
| A069 | Monoclonal antibody to gliadin (clone XGY23) | 1 mg |
| A070 | Monoclonal antibody to gliadin (clone XGY24) | 1 mg |
| A071 | Monoclonal antibody to hordein (clone XH4) | 1 mg |
| A072 | polyclonal antibody to mouse tissue Transglutaminse | 200 ug |
| A074 | Polyclonal antibody to human blood coagulation factor XIII (B-subunit) | 200 ug |
| A075 | FITC-labeled polyclonal antibody to mouse TG2 | 200 ug |
| A076 | DD-XLink-mab | 100 ug |
| A077 | FITC-labeled polyclonal antibody to human factor XIII (B-subunit) | 200 ug |
| A078 | Polyclonal antibody to human epidermal transglutaminase (TG3) Protein A | 250 ug |
| A079 | Biotin-DD-XLink-mab | 50 ug |
| A082 | Monoclonal antibody to human TG3 (clone XTG45) | 200 ug |
| A101 | FXIII-Assay Substance, Abz-NE(CAD-DNP)EQVSPLTLLK-OH | 10 mg |
| A102 | TG2-Assay Substance. Abz-APE(CAD-DNP)QEA-OH | 10 mg |
| A105 | NQEQVSPLTLLK, alpha2-Antiplasmin peptide (1-12) | 25 mg |
| A106 | (ATTO-48 8TM)cadaveri ne | 1 mg |
| A108 | Ac-(D)-Asp-MA-N le-Nle-Leu-Pro-Trp-Pro-OH | 5 mg |
| A109 | β-Amyloid peptide 1-42 (Aβ 1-42) | 1 mg |
| A112 | (ATTO-532)cadaverine | 1 mg |
| A113 | (ATTO-550)cadaverine | 1 mg |
| A114 | (AnO-647N)cadaverine | 1 mg |
| A115 | (ATTO-700)cadaverme | 1 mg |
| A125 | Factor XIII activation peptide | 10 mg |
| A132 | Ac-WALQRPHYSYPD | 10 mg |
| A139 | Monoclonal antibody to human TG6 (Catalytic Domain, clone XTG52) | 200 ug |
| A140 | Monoclonal antibody to human TG6 (Beta Barrel 1 Domain, clone XTG39) | 200 ug |
| A141 | Monoclonal antibody to human TG6 (Beta Barrel 1 Domain, clone XTG68) | 200 ug |
| A142 | Monoclonal antibody to human TG6 (Beta Barrel 2 Domain, clone XTG57) | 200 ug |
| A143 | Monoclonal antibody to microbial Transglutaminase (clone XM67) | 200 ug |
| A144 | Monoclonal antibody to microbial Transglutaminase (clone XM68) | 200 ug |
| A145 | Polyclonal Antibody to microbial Transglutaminase | 200 ug |
| A152 | 3-Azido-l -propanamine | 100 mg |
| A153 | 4-Azidobutan-l-amine | 100 mg |
| A154 | Monoclonal antibody to human factor XIII (Activation Peptide, clone XTG09) | 200 ug |
| A155 | Monoclonal antibody to human factor XIII (Catalytic Domain, clone XTG02) | 200 ug |
| B001 | Biotinyl-Thr-Val-GIn-GIn-Glu-Leu-OH | 5 mg 25 mg |
| B002 | N-(Biotinyl)cadaverine | 25 mg 100 mg |
| B003 | Boc-DON-Gln-lle-Val-OMez "Boc-DON” | 10 mg |
| B006 | Thr-Val-Gln-Gln-Glu-Leu-OH | 25 mg |
| B007 | Keratinocyte transglutaminase (TGI )-substrate-peptide K5 | 10 mg |
| B008 | Tissue transglutaminase (TG2)-substrate-peptide T26 | 10 mg |
| B009 | Epidermal transglutaminase (TG3)-substrate-peptide E51 | 10 mg |
| B010 | Blood coagulation FXIII-substrate-peptide Fl 1 KA | 10 mg |
| B013 | Neuronal transglutaminase (TG6)-substrate peptide Y25 | 10 mg |
| B014 | Transglutaminase 7 (TG7)-substrate peptide Z3S | 10 mg |
| B015 | Biotin-Ahx-MA-QPL-OMe | 10 mg |
| B017 | Microbial Transglutaminase (MTG)-substrate peptide M48 | 10 mg |
| B019 | Biotin-Ahx-QVPL-OMe | 10 mg |
| C001 | Z-GIn-Gly-OH | 1g |
| C002 | Z-GIn-Gly-CAD-DNS | 25 mg 100 mg |
| C074 | Z-Gln-Gly-CAD-(AnO-488) | 1 mg |
| C075 | Z-Gln-Gly-CAD-(ATTO-532) | 1 mg |
| C076 | Z-Gln-Gly-CAD-(AnO-550) | 1 mg |
| C077 | Z-Gln-Gly-CAD-(ATTO-647N) | 1 mg |
| C078 | Z-Gln-Gly-CAD-(AnO-700) | 1 mg |
| C079 | Z-GIn-Gly-PEG(3)-N3 | 25 mg |
| C080 | Z-Gln-Gly-PEG(11)-N3 | 25 mg |
| C090 | Z-GIn-Gly-CAD-TAMRA | 25 mg |
| C091 | Z-GIn-Gly-CAD-Biotin | 25 mg |
| C092 | Z-Gln-Gly-(PEG1,088), monodisperse | 25 mg |
| C093 | Z-Gln-Gly-(PEG5,000), polydisperse | 25 mg |
| C094 | Tosyl-ε-aminopentyl-CMK | 1 mg |
| C095 | Dansyl-ε-aminopentyl-CMK | 1 mg |
| C102 | MTG Blocker | 10 mg 25 mg |
| D001 | Dansyl-ε-aminohexanoyl-GIn-GIn-lle-Val-OH | 25 mg 100 mg |
| D002 | N-(2,4-Dinitrophenyl)cadaverine | 100 mg |
| D003 | 1,3-Dimethyl-2[(2-oxo-propyl)thio]imidazolium chloride | 100 mg |
| D004 | 1,3-Dimelhyl-4,5-diphenyl-2-[(2-oxopropyl)thio]imidazolium | 10 mg |
| D005 | Metalloprotease-Assay-Substance, DABCYL-Ser-Phe-EDANS | 2 mg |
| D006 | N-(Dansyl)cadaverine | 100 mg |
| D007 | Cadaverine | 100 mg |
| D008 | "DALP", DNP-aminohexanoic acid-Lys-aminopropanol | 5 mg |
| D009 | DALP-methyl carbamate | 5 mg |
| D0I 6 | LDN 27219 | 10 mg |
| E018 | ZediXclusive Tissue Transglutaminase EIA | 1 Kit |
| E021 | ZediXclusive Microbial Transglutaminase (MTG) ELISA | 1 Kit |
| E103 | ZediXclusive TG6-ab ELISA (IgA) | 1 Kit (96 wells) |
| E104 | ZediXclusive TG6-ab ELISA (IgG) | 1 Kit (96 wells) |
| F001 | FXIII-Assay Kit | 1 Kit |
| F002 | Tissue Transglutaminase Assay Kit | 1 Kit |
| F004 | Fibrinogen, purified from human plasma | 50 mg |
| F006 | FITC-labeled Fibrinogen | 5 mg |
| F007 | Fibrin Glue (porcine) | 1 Kit |
| F008 | Fibrin Glue (bovine) | 1 Kit |
| F011 | Cross-linked fibrin degradation products, xFDPs | 200 ug |
| F012 | Fibrin degradation products, FDPs | 200 ug |
| G001 | Alpha2-gliadin, 33mer (aa56-88), biotinylated | 5 mg |
| G002 | Deamidated alpha2-gliadin, 33mer (aa56-88), biotinylated | 5 mg |
| G003 | Ac-PLQPEQPFPK(ε-Biotin), Deamidated gliodin peptide | 10 mg |
| G004 | Ac-PEQLPQFEEK(ε-Biotin), Deamidated gliadin peptide | 10 mg |
| G005 | DGPx4 (Fusion protein of 4 deamidated gliadin peptides) | 500 ug |
| G006 | DGPx2 (Fusion protein of 2 deamidated gliadin peptides) | 500 ug |
| G007 | DGPxl (deamidated gliadin peptide) | 500 ug |
| G008 | Omega-5 gliadin | 500 ug |
| G009 | Alpha2-gliadin, 33mer (aa 56-88) | 5 mg |
| G011 | Deamidated alpha2-gliadin, 33mer, (Acetyl-aa56-88-amide, Q65E) | 5 mg |
| G013 | QPFPQPQLPYPQPQ-amide | 10 mg |
| G014 | QPFPQPELPYPQPQ-amide | 10 mg |
| G017 | Biotinylated DGPx1 | 100 ug |
| G018 | Barley albumin and globulin | 5 mg |
| G019 | Barley prolamin (Hordein) | 5 mg |
| G020 | Barley glutelin (Hordenin) | 5 mg |
| G021 | Rye albumin and globulin | 5 mg |
| G022 | Rye prolamin (Secalin) | 5 mg |
| G023 | Rye glutelin (Secalinin) | 5 mg |
| G024 | Corn albumin and globulin | 5 mg |
| G025 | Corn prolamin (Zein) | 5 mg |
| G026 | Corn glutelin (Zeanin) | 5 mg |
| G027 | Rice albumin and globulin | 5 mg |
| G028 | Rice prolamin (Oryzin) | 5 mg |
| G029 | Rice glutelin (Oryzenin) | 5 mg |
| G030 | Spell albumin and globulin | 5 mg |
| G031 | Spelt prolamin | 5 mg |
| G032 | Spelt glutelin | 5 mg |
| G033 | Oat albumin and globulin | 5 mg |
| G034 | Oat prolamin (Avenin) | 5 mg |
| G035 | Oat glutelin (Avenalin) | 5 mg |
| G036 | Wheat albumin and globulin (Leukosin and Edestin) | 5 mg |
| G037 | Wheat prolamin (Gliadin) | 5 mg |
| G038 | Wheat glutelin (Glutenin) | 5 mg |
| G039 | Durum wheat albumin and globulin | 5 mg |
| G040 | Durum wheat prolamin | 5 mg |
| G041 | Durum wheat glutelin | 5 mg |
| G042 | Soy protein, saline soluble fraction | 5 mg |
| G043 | Soy protein, ethanol soluble fraction | 5 mg |
| G044 | Soy protein, propanol/urea/DTE soluble fraction | 5 mg |
| G045 | Millet (Sorghum) albumin and globulin | 5 mg |
| G046 | Millet (Sorghum) prolamin (Kafirin) | 5 mg |
| G047 | Millet (Sorghum) glutelin | 5 mg |
| G048 | L-Glutamic acid γ-monohydroxamate | 100 mg |
| G051 | 26mer gliadin peptide | 250 ug |
| G052 | 33mer gliadin peptide | 250 ug |
| G054 | 33mer DGP | 250 ug |
| G055 | Carrier protein control | 250 ug |
| G056 | DGP and Gliadin peptides (Set No 1) | 1 Set |
| G057 | Alpha2-gliadin, 33mer (aa56-88), TAMRA labeled | 5 mg |
| G058 | Alpha2-gliadin, 33mer (aa56-88), TAMRA and Biotin labeled | 5 mg |
| G101 | Gly-Pro-Arg-Pro-amide | 25 mg |
| I001 | Involucrme, recombinant human | 500 ug |
| K004 | "KxD", Boc-Lys-en-DNS | 10 mg |
| L001 | Substrate Finder Kit | 1 Kit |
| L101 | Biotin TGase Protein Q-Labeling Kit | 1 Kit |
| L102 | PEG1,088 TGase Protein Q-Labeling Kit | 1 Kit |
| L103 | PEG5,000 TGase Protein Q-Labeling Kit | 1 kit |
| L104 | ATTO-488™ TGase Protein Q-Labeling Kit | 1 Kit |
| L105 | ATTO-532™ TGase Protein Q-Labeling Kit | 1 Kit |
| L106 | ATTO-550™ TGase Protein Q-Labeling Kit | 1 Kit |
| L107 | ATTO-647N™ TGase Protein Q-Labeling Kit | 1 Kit |
| L108 | ATTO-700™ TGase Protein Q-Labeling Kit | 1 Kit |
| L201 | Biotin TGase Protein K-Labeling Kit | 1 Kit |
| L202 | PEG1,088 TGase Protein K-Labeling Kit | 1 Kit |
| L203 | PEG5,000 TGase Protein K-Labeling Kit | 1 Kit |
| L204 | ATTO-488™ TGase Protein K-Labeling Kit | 1 Kit |
| L205 | ATTO-532™ TGase Protein K-Labeling Kit | 1 Kit |
| L206 | ATTO-550™ TGase Protein K-Labeling Kit | 1 Kit |
| L207 | ATTO-647N™ TGase Protein K-Labeling Kit | 1 Kit |
| L208 | ATTO-700™ TGase Protein K-Labeling Kit | 1 Kit |
| M001 | MTG-ANiTA-Kit | 1 Kit |
| M003 | Tissue Transglutaminase Pico-Assay Kit | 1 Kit |
| P003 | Prolylendopeptidase from Myxococcus xanthus, recombinant | 150U |
| P004 | PT-Gluten | 1 mg 10 mg |
| P009 | human Pro-Glu-Plasminogen, recombinant | 100 ug |
| P010 | (PEG1,088)amine, monodisperse | 10 mg |
| P011 | (PEG5,000)amine, polydisperse | 10 mg |
| P012 | human Plasmin, recombinant | 100 ug |
| P0U | Urokinase | 1 mg |
| P015 | Streptokinase (bacterial plasminogen activator) | 1 mg |
| P016 | Tissue Plasminogen Activator | 100 ug |
| P111 | PEPperCHIP Pan-Transglutaminase Microarray | 1 Chip |
| P112 | PEPperCHIP Custom Transglutaminase Microarray | 1 Chip |
| P113 | PEPperCHIP Transglutaminase Microarray Service | 1 Sample |
| P114 | PepSlide Analyzer | 3-Month/1-Year/Perpetual License |
| P115 | PEPperCHIP Incubation Tray 3/1 | 1 Tray |
| P116 | PEPperCHIP Staining Kit | 1 Kit |
| P117 | PEPperCHIP Transglutaminase 2 Microarray | 1 Chip |
| P118 | PEPperCHIP Incubation Tray 3/5 | 1 Tray |
| R001 | N-(Tetrametylrhodaminyl)cadaverine | 10 mg |
| R002 | TAMRA-DON | 5 mg 10 mg |
| T001 | Microbial (bacterial) transglutaminase | 25 U; 1 x 250 U;10x 25 U; lx 500 U; 20x 25 U |
| T002 | Human tissue transglutaminase (TG2) | 250 ug 1mg |
| T004 | N-(p-Tosyl)-Gly-Pro-Lys-pNA | 25 mg |
| T006 | Guinea pig liver transglutaminase | 10U |
| T009 | Human keratinocyte transglutaminase (TG1) | 150 ug |
| T011 | Human transglutaminase 7 | 250 ug |
| T013 | Human epidermal transglutaminase, Dispose activated | 200 ug |
| T016 | Microbial (bacterial) Pro-transglutaminase | 250 ug |
| T018 | Inactive human tissue transglutaminase | 250 ug 1 mg |
| T021 | Human neuronal transglutaminase (TG6) | 250 ug |
| T022 | Human tissue transglutaminase (TG2) | 250 ug 1 mg |
| T024 | Human epidermal transglutaminase (TG3) | 200 ug |
| T027 | Human blood coagulation Factor Xlll-A z recombinant | 200 ug |
| T034 | Human tissue transglutaminase (TG2) | 100 ug |
| T035 | Human keratinocyte transglutaminase (TGI) | 150 ug |
| T036 | Transglutaminase Assay Kit, fluorescent, Casein, Dansylcadaverine | 1 Kit |
| T038 | Rat tissue transglutaminase | 250 ug 1 mg |
| T039 | Guinea pig liver transglutaminase, recombinant | 10U |
| T040 | Mouse tissue transglutaminase | 250 ug 1 mg |
| T042 | Human prostate Transglutaminase (TG4) | 100 ug |
| T050 | Human blood coagulation Factor XIII B subunit | 200 ug |
| T051 | Open tTG™ | 250 ug |
| T055 | Tissue Transglutaminase Microassay Kit, colorimetric | 1 Kit |
| T056 | Human alpha thrombin, highly active | 200 U |
| T057 | Inhibited human epidermal transglutaminase | 250 ug |
| T061 | Mouse blood coagulation Factor Xlll-A2 | 200 ug |
| T062 | Dog blood coagulation Factor Xlll-A2 | 200 ug |
| T063 | Human blood coagulation Factor Xlll-A2 , Val34Leu-mutant | 200 ug |
| T064 | Inhibited human neuronal transglutaminase | 250 ug |
| T065 | Rat blood coagulation Factor Xlll-A2 | 200 ug |
| T066 | Pig blood coagulation Factor Xlll-A2 | 200 ug |
| T067 | Human tissue transglutaminase (TG2), endotoxin free | 250 ug 1 mg |
| T070 | Human Factor Xllla, Thrombin activated | 200 ug |
| T072 | Dog tissue transglutaminase | 250 ug 1 mg |
| T086 | Human Transglutaminase 5 | 100 ug |
| T087 | Tridegin | 200 ug |
| T092 | Human blood coagulation Factor Xlll-A2 | 100 ug |
| T101 | 1,3,4,5-Tetramethyl-2[(2-oxo-propyl)thio] imidazolium chloride | 10 mg |
| T102 | Mouse Open TG2 | 250 ug 1 mg |
| T106 | Biotinylated human tissue transglutaminase (TG2) | 100 ug 250 ug |
| T108 | Cynomolgus tissue transglutaminase | 250 ug |
| T109 | Cynomolgus open TG2 | 100 ug |
| T1 10 | Recombinant TG2 [E.coli] | 500 ug |
| T1 14 | Blood Coagulation Factor Xlll-Microassay Kit, colorimetric | 1 Kit |
| T117 | Biotinylated inactive hTG2 (Cys277Ser) | 250 ug 1 mg |
| T122 | Recombinant TG2 (insect cells) | 500 ug |
| T123 | Biotinylated human tissue transglutaminase (TG2) | 50 ug |
| T124 | Recombinant TG3 (insect cells) | 400 ug |
| T127 | Biotinylated human blood coagulation Factor XIII | 50 ug |
| T134 | Open tTG™ | 100 ug |
| T139 | Rabbit tissue transglutaminase | 250 ug 1mg |
| T140 | Biotinylated human epidermal transglutaminase | 100 ug |
| T141 | Biotinylated human neuronal transglutaminase | 100 ug |
| T142 | Biotinylated mouse blood coagulation Factor Xlll-A2 | 50 ug |
| T146 | Mouse neuronal transglutaminase | 250 ug |
| T148 | Biotinylated human Open tTG™ | 50 ug 1 mg |
| T149 | Oxidized inactive human tissue transglutaminase | 250 ug 1 mg |
| T150 | Biotinylated mouse open TG2 | 50 ug |
| T151 | Biotinylated oxidized inactive human tissue transglutaminase | 250 ug 1 mg |
| T152 | Rabbit blood coagulation Factor Xlll-A2 | 200 ug |
| T153 | Microbial (bacterial) transglutaminase, edotoxin free | 25 U;10x 25 U;20x 25 U |
| T156 | Biotinylated mouse tissue transglutaminase | 250 ug; 1 mg |
| T159 | Pig tissue transglutaminase | 250 ug; 1 mg |
| T160 | Biotinylated cynomolgus tissue transglutaminase | 50 ug |
| T161 | Cynomolgus blood coagulation Factor Xlll-A2 | 200 ug |
| T167 | Short human tissue transglutaminase, aa 1-475 | 250 ug |
| T168 | Human tissue transglutaminase, C23OA mutant | 250 ug;1 mg |
| T169 | Human tissue transglutaminase, R580A mutant | 250 ug;1 mg |
| T173 | Human tissue transglutaminase, R116C mutant | 1 mg |
| T178 | Microbial transglutaminase with C-terminal His6-tag | 25 U;10 x 25 U;20 x 25 U |
| T184 | Cat tissue transglutaminase | 200 ug |
| T187 | Factor XIII activation peptide, recombinant | 500 ug |
| T197 | Coagulation factor XIII, recombinant human Factor Xlll-A2 | 100E;250E |
| T222 | Human alpha Thrombin, recombinant | 100 NIH Units |
| Z004 | Z-Gln-GIn-Pro-Leu-OH | 25 mg |
| Z006 | Z-DON-Val-Pro-Leu-OMe,"Z-DON" | 10 mg |
| Z009 | ZediXclusive Microbial Transglutaminase Assay Kit | 1 Kit |
| Z010 | ZediXclusive Tissue Transglutaminase Assay Kit | 1 Kit |
| Z011 | Z-(D)-DON-Val-Pro-Leu-OMe | 10 mg |
| Z013 | Z-MA-QPL-OMe | 10 mg |
| Z015 | Keillor inhibitor AA9 | 10 mg |
| Z016 | Keillor inhibitor NC9 | 10 mg |
| Z017 | Keillor inhibitor VA4 | 10 mg |

艾美捷科技代理Seramun Diagnostica品牌产品。
Seramun Diagnostica GmbH主要产品为质控试剂盒:卵清蛋白检测试剂盒 E041A,广泛应用于流感、狂犬、脊髓灰质炎等疫苗的生产质控。Seramun Diagnostica GmbH 是一家专注于开发和制造高质量体外诊断(IVD)试剂和设备的公司,总部位于德国黑森州的海登罗德(Heidenrod)。公司成立于 1994 年,致力于为临床实验室、研究机构和医疗保健提供商提供创新的诊断解决方案。Seramun Diagnostica 的产品以其高灵敏度、高特异性和可靠性而闻名,广泛应用于传染病、自身免疫疾病和过敏原检测等领域。
(1)传染病诊断:提供用于检测病毒、细菌和寄生虫感染的诊断试剂,如 ELISA 试剂盒和快速检测试剂盒。支持 HIV、肝炎、流感、莱姆病等传染病的诊断。
(2)自身免疫疾病诊断:开发用于检测自身抗体的诊断试剂,支持类风湿性关节炎、系统性红斑狼疮等自身免疫疾病的诊断。
(3)过敏原检测:提供用于检测过敏原特异性 IgE 抗体的试剂,支持食物过敏、花粉过敏等过敏原的诊断。
(4)临床化学和免疫分析:提供用于临床化学和免疫分析的试剂和设备,支持生物标志物检测和疾病监测。
" data-original="http://biomatik.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Seramun Diagnostica品牌产品"> 艾美捷科技代理Seramun Diagnostica品牌产品

艾美捷科技代理Eton Bioscience品牌。
Eton Bioscience公司位于圣地亚哥,自2003年成立以来,一直为学术界和工业界提供高质量DNA测序和寡核苷酸合成服务。在这个过程中,Eton Bioscience形成了自己的产品线,产品包括:激酶、连接试剂盒、代谢分析试剂盒、核酸酶和蛋白酶。
" data-original="http://biomatik.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Eton Bioscience品牌"> 艾美捷科技代理Eton Bioscience品牌
艾美捷科技代理Abliance品牌全系列产品
Abliance是一家法国的抗体制造商和服务提供商,由专家组成的团队,在细胞培养、蛋白质工程和质量控制方面拥有深厚专业知识,专注为体外诊断(IVD)及科研领域提供高合规性抗体解决方案,满足研究和诊断工业市场的抗体需求。
▍Abliance公司产品提供丰富可选择的抗体库
| 多物种来源 | 多特异性靶点 | 多样标记方式 | 多级适用品质 |
| anti-human Ig | anti-IgG, IgM, IgA | fluorescent | globulins |
| anti-mouse and rabbit Ig | anti-IgGAM | enzymatic | affinity purified antibodies |
| anti-goat, bovine, dog Ig ... | anti-Fc and Fab fragments | biotin | Fab and F(ab')2 fragments |
● Abliance的二抗产品为多克隆抗体,通过使用人或动物免疫球蛋白对实验动物(兔、山羊或绵羊)进行高效免疫后获得。收集的免疫血清除含有目标特异性抗体外,还包含非特异性抗体及血清杂蛋白。
● Globulins:经过系列非特异性纯化步骤(脱脂处理→硫酸铵沉淀→透析)后获得球蛋白组分,此中间产物适用于免疫沉淀技术。
● Affinity purified antibodies:随后通过亲和层析对抗体进行纯化,从而确保高特异性。此外,抗鼠/兔IgG(H+L)二抗需在装有人源IgA/IgG/IgM的凝胶层析柱上进行系统化吸附处理,确保其与人源IgA/IgG/IgM无交叉反应。
● Fragments:Abliance提供经酶切获得的F(ab')₂和Fab片段,适用于免疫组化/细胞学检测及流式细胞术等场景。相较于含Fc区的完整抗体,这些片段能显著降低非特异性结合。其更小的分子量可增强细胞和组织渗透性。
● Labeled antibodies:Abliance供应多样标记物复合体:球蛋白组分、纯化抗体及Fab/F(ab')₂片段,可与荧光染料(异硫氰酸荧光素)、酶类(过氧化物酶、碱性磷酸酶、β-半乳糖苷酶、葡萄糖氧化酶)及生物素进行偶联。

▍Abliance部分产品列表
| 货号 | 品名 | 规格 | Host | Antigen |
| BI 1014 | Anti-Human IgGAM Globulin | 4mg/2ml | Goat | Human IgGAM |
| BI 1015 | Anti-Human IgG (H+L) Globulin | 4mg/2ml | Goat | Human IgG (H+L) |
| BI 1016 | Anti-Human IgA (alpha) Globulin | 4mg/2ml | Goat | Human IgA (alpha) |
| BI 1018 | Anti-Human IgG (gamma) Globulin | 4mg/2ml | Goat | Human IgG (gamma) |
| BI 1019 | Anti-Human IgM (µ) Globulin | 4mg/2ml | Goat | Human IgM (µ) |
| BI 1025 | Anti-Human albumin Globulin | 4mg/2ml | Goat | Human albumin |
| BI 3014 | Anti-Human IgGAM Fab | 2mg/1ml | Goat | Human IgGAM |
| BI 3015 | Anti-Human IgG (H+L) Fab | 2mg/1ml | Goat | Human IgG (H+L) |
| BI 3016 | Anti-Human IgA (alpha) Fab | 2mg/1ml | Goat | Human IgA (alpha) |
| BI 3018 | Anti-Human IgG (gamma) Fab | 2mg/1ml | Goat | Human IgG (gamma) |
| BI 3019 | Anti-Human IgM (µ) Fab Goat | 2mg/1ml | Goat | Human IgM (µ) |
| BI 3025 | Anti-Human albumin Fab | 2mg/1ml | Goat | Human albumin |
| BI 4015 | Anti-Human IgG (H+L) F(ab')2 | 2mg/1ml | Goat | Human IgG (H+L) |
| BI 4016 | Anti-Human IgA (alpha) F(ab')2 | 2mg/1ml | Goat | Human IgA (alpha) |
| BI 4018 | Anti-Human IgG (gamma) F(ab')2 | 2mg/1ml | Goat | Human IgG (gamma) |
| BI 4019 | Anti-Human IgM (µ) F(ab')2 | 2mg/1ml | Goat | Human IgM (µ) |
| BI 4025 | Anti-Human albumin F(ab')2 | 2mg/1ml | Goat | Human albumin |
| BI 3414 | Anti-Human IgGAM Fab HRP | 1ml | Goat | Human IgGAM |
| BI 3415 | Anti-Human IgG (H+L) Fab HRP | 1ml | Goat | Human IgG (H+L) |
| BI 3416 | Anti-Human IgA (alpha) Fab HRP | 1ml | Goat | Human IgA (alpha) |
| BI 3418 | Anti-Human IgG (gamma) Fab HRP | 1ml | Goat | Human IgG (gamma) |
| BI 3419 | Anti-Human IgM (µ) Fab HRP | 1ml | Goat | Human IgM (µ) |
| BI 3425 | Anti-Human albumin Fab HRP | 1ml | Goat | Human albumin |
| BI 4414 | Anti-Human IgGAM F(ab')2 HRP | 1ml | Goat | Human IgGAM |
| BI 4415 | Anti-Human IgG (H+L) F(ab')2 HRP | 1ml | Goat | Human IgG (H+L) |
| BI 4419 | Anti-Human IgM (µ) F(ab')2 HRP | 1ml | Goat | Human IgM (µ) |
| BI 4425 | Anti-Human albumin F(ab')2 HRP | 1ml | Goat | Human albumin |

Prozyme公司位于美国加州,为广大客户提供诊断和科研所需的标记物、蛋白质与酶。Prozyme 于2003年1月收购了Glyko®产品线,包括研究糖类的酶及相关试剂。其中也包括Glyko®于1999年收购的Oxford GlycoSciences,Ltd 公司生化试剂产品线。
ProZyme is now a part of Agilent Technologies, Inc.
ProZyme, Inc. was founded in 1990 with a vision of establishing a high-quality, value-added and customer-driven biochemical reagent company. We are proud to continue to provide the highest level of products, services and support to our customers at large and small biotechnology, biopharmaceutical and academic institutions across the world.
ProZyme公司产品系列:
(1)糖生物学研究工具(Glyko.系列)
(2)PhycoLink. 荧光结合试剂( 抗体/ 蛋白标记) PE, PerCP conjugates, BPE conjugates, CPC conjugates,生物素,纯化试剂盒,结合试剂盒,标记二抗
(3)PhycoLink.纯化与标记试剂盒/ Purification and Conjugation Kits
(4) PhycoProTM 藻胆蛋白/ Phycobiliproteins
(5)生物素结合蛋白/ Biotin-binding Proteins 链亲和素
(6)固定化链亲和素/ Immobilized Streptavidin 琼脂糖-链亲和素
(7))链亲和素结合物/ Streptavidin Conjugates 链亲和素- AP,链亲和素- HRP
(8) Marker Enzyme 半乳糖苷酶
(9)位点特异性蛋白酶/ Site-specific Protease Factor Xa (lyophilized)
(10)客户定制结合服务或其他
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com

艾美捷科技代理Nacalai Tesque 品牌。
Nacalai Tesque成立于1980年,Nacalai Tesque专注于精细化学品和研究化学品的研发、生产和销售,特别是生命科学试剂领域。公司通过了ISO 9001、ISO 9002和ISO 14001等国际标准的认证,确保了产品质量和生产环境的可靠性。Nacalai Tesque的产品线广泛,涵盖了生命科学研究的多个方面.
主要包括:
(1)高效液相色谱柱(HPLC柱):该公司生产的高效液相色谱柱不仅基于C18化学,还包括特种化学的色谱柱,能够分离和分析难以用标准C18色谱柱分离的化合物。
(2)细胞培养基及相关产品:提供全面的细胞培养基,包括补充剂、抗生素、小分子、蛋白质等,满足各种细胞培养需求。
(3)蛋白质研究检测试剂盒:支持蛋白质电泳、蛋白质印迹和免疫组织化学等多种应用,为蛋白质研究提供可靠的解决方案。
(4)缓冲液:提供用于分子生物学、细胞生物学、免疫学、神经生物学等领域的缓冲液,确保在各种研究应用中获得高质量的结果。
此外,Nacalai Tesque还生产毒素、抗体、酶等生命科学试剂,以及分离试剂盒、生物试剂和精细化学品等。
<<<<< " data-original="http://biomatik.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Nacalai Tesque品牌"> 艾美捷科技代理Nacalai Tesque品牌
艾美捷科技代理Technoclone 品牌。
Technoclone重要的止血和纤维蛋白溶解领域诊断测试、设备和研究产品的生产商。除了拥有全面的常规和专科测试产品组合,Technoclone还改进了其全自动Ceveron alpha/alpha TGA仪器,推出了新的Ceveron 100系列仪器。凭借超过10年的全自动凝血生成测试经验,新的Ceveron 100系列产品将TGA测试能力提高了50%。此外,通过在顶级系统Ceveron s100上使用淬火技术,Technoclone提供了全球首款全自动止血分析仪,能够同时运行常规和专科测试,包括全自动凝血生成、ADAMTS13活性和因子XIII活性。
Technoclone产品和平台包括:
(1)针对凝血和纤溶系统成分的单克隆抗体:这些单克隆抗体用于检测凝血和纤溶系统中的特定成分,有助于了解止血功能状态。
(2)全自动凝血酶生成测试:这是一项先进的体外诊断测试,用于评估凝血酶的生成情况,有助于诊断凝血障碍和其他相关疾病。
(3)测试、校准器和控制器:Technoclone提供一系列全球测试和校准工具,确保诊断设备的准确性和可靠性。
(4)因子分析:用于分析凝血和纤溶系统中的各种因子,帮助医生确定患者是否存在特定的凝血障碍或疾病。
(5)血管性血友病和TTP(血栓性血小板减少性紫癜)相关测试:提供针对这些特定疾病的诊断测试,有助于早期发现和有效治疗。
(6)抗凝治疗监测:为接受抗凝治疗的患者提供监测工具,以确保治疗的有效性和安全性。
(7)辅助试剂和系列研究型产品:为满足科研和特殊诊断需求,提供一系列辅助试剂和研究型产品。
<<<<< " data-original="http://biomatik.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Technoclone品牌"> 艾美捷科技代理Technoclone品牌
艾美捷科技代理Sorachim品牌。
Sorachim公司提供诊断试剂专用酶:脂肪酶、过氧化物酶、尿酸酶,辅酶:NADH、NADPH、NADP;底物:TMB、双甘氨肽等 IVD 行业专用试剂。Sorachim 是一家专注于为制药、生物技术、化妆品和食品行业提供高质量化学原料和定制化解决方案的公司。公司成立于 1986 年,总部位于法国,凭借其广泛的产品组合、严格的质量控制和卓越的客户服务,已成为欧洲化学原料领域的重要供应商之一。Sorachim 的产品广泛应用于药物开发、化妆品配方、食品添加剂和工业应用等领域,包括:
制药原料:Sorachim 提供用于药物开发的化学原料,包括活性药物成分(API)、中间体、辅料和溶剂。
化妆品原料:提供用于化妆品配方的化学原料,如乳化剂、增稠剂、防腐剂和功能性添加剂。
食品添加剂:提供用于食品工业的化学原料,如乳化剂、稳定剂、防腐剂和香料。
工业化学品:公司为工业应用提供特种化学品,如表面活性剂、溶剂、涂料和油墨添加剂。
<< " data-original="http://biomatik.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Sorachim品牌"> 艾美捷科技代理Sorachim品牌

Affinity Biosciences成立于2006年,是一家开创性的生命科学和高科技公司,其生化产品和服务主要应用于生物技术,医学研究和药物开发。Affinity Biosciences致力于通过创新推动客户成功,在英国和美国建立了研发部门,旨在为全球提供卓越的服务。我们的客户包括科学家和技术人员在生命科学公司,大学和政府机构,医院和行业。为了强化对客户的承诺,提升服务水平,我们在中华人民共和国开设了包装和质量控制设施。我们的目标是开发重点是细胞信号转导研究的高质量抗体,包括Akt,AMPK,NF-KappaB,TGF-β等,以及抑制剂和相关试剂。
Founded in 2006, Affinity Biosciences is a pioneering Life Science and High-Tech company whose biochemical products and services are mainly applied in biotechnology, medical research and pharmaceutical development.
Dedicating to advancing customer success through innovation, Affinity Biosciences has established R&D affiliates in the United Kingdom and United States with the aim of providing outstanding service around the globe.Our customers include scientists and technologists in life science companies, university and government institutions, hospitals and industry. To underline our commitment to our customers and enhance our standards of service, we have opened packaging and quality control facilities in the People’s Republic of China. Our goal is to develop high-quality antibody that focuses on Cell Signaling Transduction research, including Akt,AMPK,NF-KappaB,TGF-beta,etc,as well as inhibitors and related reagents.
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
" data-original="http://biomatik.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Affinity Biosciences"> Affinity Biosciences
艾美捷科技代理深圳鼎升(AcroGenic)全系列产品。
深圳鼎升生物科技有限公司成立于2022年7月29日,坐落在深圳光明区。公司专注于新一代合成生物材料研发及其在新兴生物医药领域中的应用,依托拥有中美自主专利的新型3D可调控高分
子合成生物材料 AccuraMatrix ®技术,实现产品化及市场化。
AcroGenic主营业务基于细胞三维培养和体内外模型平台建立及试剂耗材的生产,治疗性细胞的体外规模化生产及体内植入技术研究及市场化,合成生物平台的建立及合成产品的生产销售。
目前公司已设立北京、深圳和美国的研发及生产中心。
产品范围包括:
(1)AccuraMatrix®细胞外基质

人工合成的有机共聚大分子生物3D架构,能有效模拟细胞生长所需的稳定微环境。
拥有中美自主专利技术,可对架构的孔径大小、结构刚性等理化指标进行调节。
AccuraMatrix可根据培养细胞、细胞球、类器官及组织颗粒的培养需要,通过各类生物材料的不断开发和优化以达到在体外最大限度地模仿体内微环境从而实现多种人类干细胞及原代细胞的体外三维高密度大规模培养、扩增及体内外模型建立。AccuraMatrix细胞外基质产品有普适性强,生物安全性高,可植入性,低成本,高重复性和稳定批次质量。可用于干细胞生产,骨和软骨修复,人造腺体,细胞体内植入。
<<
(2)CTC体外培养试剂盒

肺癌循环肿瘤细胞培养试剂盒
肝癌循环肿瘤细胞培养试剂盒
肾癌循环肿瘤细胞培养试剂盒
胆管癌循环肿瘤细胞培养试剂盒
胰腺癌循环肿瘤细胞培养试剂盒
卵巢癌循环肿瘤细胞培养试剂盒
在AccuraMatrix系统可从外周血中体外培养、增殖,获得足够的数量的CTC,进行全面的分子与功能研究,如对肿瘤细胞与正常细胞物理特性差异的研究;对原发性肿瘤、CTC和转移灶进行基因表达谱的比较;对CTC不同表面标志物表达的研究;对CTC进行药物敏感度实验和建立动物转移模型等。有利于肿瘤患者早期诊断、辅助临床进行精确治疗、术后肿瘤复发与转移及预后评估等。

应用场景

AccuraMatrixCTC培养可用于肿瘤无创早诊、复发监测、用药指导。细胞外生物材料技术涵盖肿瘤早、中、晚全阶段,早期高危和高度怀疑患者的诊断(液体活检,基因诊断无法确诊),
CTC可以通过对肿瘤细胞的病历诊断做到无创确诊;支持低成本长期培养,可以帮助患者建立起抗药肿瘤模型,并提前筛选出药效药物,指导肿瘤复发治疗,利用CTC培养对治疗效果进
行评估,监测肿瘤复发;晚期病人获得肿瘤样品难, 通过CTC为病人寻找有效药物和药物组合。
另外,AccuraMatrix体外培养扩增后的CTC细胞团可用于动物模型构建,支持肿瘤新药研发、监测肿瘤复发、疗效评估和用药指导。
循环肿瘤细胞体外培养 的基质材料优化及其相关临床应用产品的研发,实现了高成功率循环肿瘤细胞体外培养,建立了世界唯一的循环肿瘤细胞动物体内种植方法,成功地利用循环肿
瘤细胞动物模型进行了体内抗癌药物评估。
目前,AccuraMatrix已完成部分癌种CTC扩增培养和蛋白鉴定。
(3)类器官培养试剂盒

依托生物基质材料在体外最大限度地模拟体内微环境,实现多种类器官快速构建,并支持类器官与免疫细胞长时间共培养。为抗癌新药研发和患者治疗方案的筛选提供高效、准确、高性价比的服务,为癌症基础研究提供不可或缺的体外 3D 肿瘤模型及动物模型。
<肺癌类器官培养试剂盒
肝癌类器官培养试剂盒
肾癌类器官培养试剂盒
胆管癌类器官培养试剂盒
胰腺癌类器官培养试剂盒
结直肠癌类器官培养试剂盒
尿道上皮癌类器官培养试剂盒
胃癌类器官培养试剂盒
卵巢癌类器官培养试剂盒
乳腺癌类器官培养试剂盒
恶性体腔积液类器官培养试剂盒
肝癌组织类器官培养试剂盒


(4)利用3D培养技术体外生产治疗性蛋白
针对生物合成中存在的某些问题,通过在细胞培养中应用不同的生物材料实现了对细胞培养微环境的调控,改变了细胞状态,实现了多种细胞的共同培养,更换表达细胞种类,从而解决了一定的技术瓶颈


地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话:15172431432
传真:15172469628
邮箱:sales@amyjet.com
0.2461